Unsolved issues in the management of high blood pressure in acute ischemic stroke

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Hubert, Gordian J ^a   Müller Barna, Peter ^a   Haberl, Roman L ^a  

^a Munich Municipal Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CANDESARTAN; GLYCERYL TRINITRATE; LABETALOL; LISINOPRIL; MAGNESIUM; NIMODIPINE; PLACEBO; PROPRANOLOL;

BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN ISCHEMIA; CLINICAL DECISION MAKING; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; HUMAN; HYPERTENSION; HYPOTENSION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

EID: 84877995991     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/349782     Document Type: Review

References (40)

1. Leonardi-Bee J., Bath P. M. W., Phillips S. J., Sandercock P. A. G., Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002 33 5 1315 1320 2-s2.0-0036093482 10.1161/01.STR.0000014509.11540.66 (Pubitemid 34517053)
2. Britton M., Carlsson A., De Faire U., Blood pressure course in patients with acute stroke and matched controls. Stroke 1986 17 5 861 864 2-s2.0-0022465701 (Pubitemid 16000718)
3. Fischer U., Rothwell P. M., Blood pressure management in acute stroke. Stroke 2011 42 10 2995 2998
4. Jauch E. C., Saver J. L., Adams H. P. Jr., Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 44 3 870 947
5. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee, Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovascular Diseases 2008 25 5 457 507 10.1159/000131083 (Pubitemid 351754643)
6. The ENOS Trial Investigators, Glyceryl trinitrate versus control, and continuing versus stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). International Journal of Stroke 2006 1 4 245 249 2-s2.0-33749621388 10.1111/j.1747-4949.2006.00059.x (Pubitemid 44541740)
7. ENCHANTED. http://clinicaltrials.gov/ct2/show/NCT01422616
8. Vemmos K. N., Tsivgoulis G., Spengos K., Zakopoulos N., Synetos A., Manios E., Konstantopoulou P., Mavrikakis M., U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. Journal of Internal Medicine 2004 255 2 257 265 2-s2.0-1242317781 10.1046/j.1365-2796. 2003.01291.x (Pubitemid 38241370)
9. Willmot M., Leonardi-Bee J., Bath P. M. W., High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004 43 1 18 24 2-s2.0-0347418916 10.1161/01.HYP.0000105052.65787.35 (Pubitemid 38031905)
10. Durward Q. J., Del Maestro R. F., Amacher A. L., Farrar J. K., The influence of systemic arterial pressure and intracranial pressure on the development of cerebral vasogenic edema. Journal of Neurosurgery 1983 59 5 803 809 2-s2.0-0020545171 (Pubitemid 13021753)
11. Mayer S. A., Thomas C. E., Diamond B. E., Asymmetry of intracranial hemodynamics as an indicator of mass effect in acute intracerebral hemorrhage: a transcranial Doppler study. Stroke 1996 27 10 1788 1792 2-s2.0-0029780303 (Pubitemid 26332506)
12. Treib J., Becker S. C., Grauer M. T., Haass A., Transcranial Doppler monitoring of intracranial pressure therapy with mannitol, sorbitol and glycerol in patients with acute stroke. European Neurology 1998 40 4 212 219 2-s2.0-0031729568 (Pubitemid 28526245)
13. Hrafnkelsdóttir T., Wall U., Jern C., Jern S., Impaired capacity for endogenous fibrinolysis in essential hypertension. The Lancet 1998 352 9140 1597 1598 2-s2.0-0032517491 (Pubitemid 28515249)
14. Hrafnkelsdóttir T., Gudnason T., Wall U., Jern C., Jern S., Regulation of local availability of active tissue-type plasminogen activator in vivo in man. Journal of Thrombosis and Haemostasis 2004 2 11 1960 1968 2-s2.0-13244291340 10.1111/j.1538-7836.2004.00948.x (Pubitemid 40192750)
15. Sjögren L. S., Doroudi R., Gan L. M., Jungersten L., Hrafnkelsdóttir T., Jern S., Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression. Hypertension 2000 35 4 1002 1008 2-s2.0-0343527327 (Pubitemid 30303965)
16. Chamorro A., Vila N., Ascaso C., Elices E., Schonewille W., Blanc R., Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998 29 9 1850 1853 2-s2.0-0031685983 (Pubitemid 28399976)
17. Christensen H., Boysen G., Johannesen H. H., Christensen E., Bendtzen K., Deteriorating ischaemic stroke: cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. Journal of the Neurological Sciences 2002 201 1-2 1 7 2-s2.0-0037105955 10.1016/S0022-510X(02)00160-0 (Pubitemid 34876897)
18. Mattle H. P., Kappeler L., Arnold M., Fischer U., Nedeltchev K., Remonda L., Jakob S. M., Schroth G., Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005 36 2 264 268 2-s2.0-12844284505 10.1161/01.STR.0000153052.59113.89 (Pubitemid 40170805)
19. Oliveira-Filho J., Silva S. C. S., Trabuco C. C., Pedreira B. B., Sousa E. U., Bacellar A., Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003 61 8 1047 1051 2-s2.0-0345327766 (Pubitemid 37461935)
20. Castillo J., Leira R., García M. M., Serena J., Blanco M., Dávalos A., Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004 35 2 520 527 2-s2.0-0842289192 10.1161/01.STR.0000109769.22917.B0 (Pubitemid 38174440)
21. Barer D. H., Cruickshank J. M., Ebrahim S. B., Mitchell J. R., Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. British Medical Journal 1988 296 6624 737 741 (Pubitemid 18066502)
22. Mohr J. P., Orgogozo J. M., Harrison M. J. G., Hennerici M., Wahlgren N. G., Gelmers J. H., Martinez-Vila E., Dycka J., Tettenborn D., Meta-analysis of oral nimodipine trials in acute ischemic stroke. Cerebrovascular Diseases 1994 4 3 197 203
23. Wahlgren N. G., MacMahon D. G., de Keyser J., Indredavik B., Ryman T., Intravenous nimodipine West European stroke trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovascular Diseases 1994 4 3 204 210
24. Ahmed N., Näsman P., Wahlgren N. G., Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000 31 6 1250 1255 2-s2.0-0343963044 (Pubitemid 30351241)
25. IMAGES Investigators, Magnesium for acute stroke: randomised controlled trial. The Lancet 2004 363 439 445
26. Bath P. M. W., Pathansali R., Iddenden R., Bath F. J., The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases 2001 11 3 265 272 2-s2.0-0035052592 10.1159/000047649 (Pubitemid 32304642)
27. Rashid P., Weaver C., Leonardi-Bee J., Bath F., Fletcher S., Bath P., The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases 2003 12 3 143 151 2-s2.0-0038165102 10.1016/S1052-3057(03)00037-5 (Pubitemid 36870488)
28. Potter J. F., Robinson T. G., Ford G. A., Mistri A., James M., Chernova J., Jagger C., Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. The Lancet Neurology 2009 8 1 48 56 2-s2.0-57149121456 10.1016/S1474-4422(08)70263-1
29. Robinson T. G., Potter J. F., Ford G. A., Bulpitt C. J., Chernova J., Jagger C., James M. A., Knight J., Markus H. S., Mistri A. K., Poulter N. R., Effects of antihypertensive treatment after acute stroke in the continue or stop post-stroke antihypertensives collaborative study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. The Lancet Neurology 2010 9 8 767 775 2-s2.0-77955316852 10.1016/S1474-4422(10)70163-0
30. Sandset E. C., Bath P. M. W., Boysen G., Jatuzis D., Kõrv J., Lüders S., Murray G. D., Richter P. S., Roine R. O., Terént A., Thijs V., Berge E., The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. The Lancet 2011 377 9767 741 750 2-s2.0-79952103780 10.1016/S0140-6736(11)60104- 9
31. Geeganage C. M., Bath P. M. W., Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression. Hypertension 2009 54 4 775 781 2-s2.0-70349653033 10.1161/HYPERTENSIONAHA.109.133538
32. Geeganage C., Bath P. M., Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews 2008 4 CD000039 2-s2.0-58249084520
33. Geeganage C., Bath P. M., Vasoactive drugs for acute stroke. Cochrane Database of Systematic Reviews 2010 7 CD002839 2-s2.0-77955508247
34. Lees K. R., Bluhmki E., von Kummer R., Brott T. G., Toni D., Grotta J. C., Albers G. W., Kaste M., Marler J. R., Hamilton S. A., Tilley B. C., Davis S. M., Donnan G. A., Hacke W., Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. The Lancet 2010 375 9727 1695 1703 2-s2.0-77952112006 10.1016/S0140-6736(10)60491-6
35. Sandset E. C., Murray G. D., Bath P. M. W., Kjeldsen S. V., Berge E., On behalf of the Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group, Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome. Stroke 2012 43 8 2108 2114
36. Willmot M., Ghadami A., Whysall B., Clarke W., Wardlaw J., Bath P. M. W., Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006 47 6 1209 1215 2-s2.0-33744970068 10.1161/01.HYP.0000223024.02939.1e (Pubitemid 44289181)
37. Sare G. M., Gray L. J., Wardlaw J., Chen C., Bath P. M. W., Is lowering blood pressure hazardous in patients with significant ipsilateral carotid stenosis and acute ischaemic stroke? Interim assessment in the 'Efficacy of Nitric Oxide in Stroke' Trial. Blood Pressure Monitoring 2009 14 1 20 25 2-s2.0-63149174845 10.1097/MBP.0b013e32831e30bd
38. Powers W. J., Videen T. O., Diringer M. N., Aiyagari V., Zazulia A. R., Autoregulation after ischaemic stroke. Journal of Hypertension 2009 27 11 2218 2222 2-s2.0-73249122042 10.1097/HJH.0b013e328330a9a7
39. Nazir F. S., Overell J. R., Bolster A., Hilditch T. E., Lees K. R., Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial. Cerebrovascular Diseases 2005 19 2 77 83 2-s2.0-14044266223 10.1159/000082783 (Pubitemid 40278666)
40. Sare G. M., Gray L. J., Bath P. M. W., Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies. Journal of Hypertension 2008 26 6 1058 1064 2-s2.0-43449107393 10.1097/HJH.0b013e3282fbd240 (Pubitemid 351670494)